FDA Accepts NDA for Glaukos’ Corneal Cross-Linking Drug Treatment
Glaukos’ Epioxa eyes FDA approval as the first non-invasive cross-linking therapy for keratoconus. Glaukos Corporation (California, USA) announced yesterday that…
latest posts
Glaukos’ Epioxa eyes FDA approval as the first non-invasive cross-linking therapy for keratoconus. Glaukos Corporation (California, USA) announced yesterday that…